Zoledronic acid for the prevention of bone metastases in patients with breast cancer

被引：0
|
作者：
Coleman, R. [1 ]
Gralow, J. [2 ]
Bell, R. [3 ]
Lipton, A. [4 ]
机构：
[1] Acad Unit Clin Oncol, Sheffield, S Yorkshire, England
[2] Univ Washington, Sch Med Seattle Canc Care Alliance, Seattle, WA USA
[3] Andrew Love Canc Ctr, Geelong, Vic, Australia
[4] Milton S Hershey Med Ctr, Hershey, PA USA
来源：
EJC SUPPLEMENTS | 2004年 / 2卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(04)90666-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
63
引用
收藏
页码：74 / 75
页数：2
相关论文
共 50 条
  • [1] Continuing benefit of zoledronic acid for the prevention of skeletal complications in breast cancer patients with bone metastases
    Rosen, L.
    Gordon, D.
    Chen, Y. M.
    [J]. CANCER TREATMENT REVIEWS, 2006, 32 : S43 - S43
  • [2] Continuing benefit of zoledronic acid for the prevention of skeletal complications in breast cancer patients with bone metastases
    不详
    [J]. BREAST, 2005, 14 : S45 - S46
  • [3] Continuing benefit of zoledronic acid for the prevention of skeletal complications in breast cancer patients with bone metastases
    不详
    [J]. BREAST, 2005, 14 : S44 - S44
  • [4] Continuing benefit of zoledronic acid for the prevention of skeletal complications in breast cancer patients with bone metastases.
    Lipton, A.
    Chen, Y. M.
    Milton, S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S62 - S62
  • [5] Zoledronic acid is being investigated for the prevention of bone metastases in patients with early-stage breast cancer
    Coleman, R
    Gralow, J
    Bell, R
    Lipton, A
    [J]. BONE, 2004, 34 : S85 - S85
  • [6] Breast cancer bone metastases: denosumab or zoledronic acid?
    Gabri van der Pluijm
    [J]. Nature Reviews Endocrinology, 2011, 7 : 134 - 135
  • [7] CANCER Breast cancer bone metastases: denosumab or zoledronic acid?
    van der Pluijm, Gabri
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (03) : 134 - 135
  • [8] Efficacy of zoledronic acid in the prevention of bone metastases in patients with locally advanced prostate cancer
    Musaev, T. N.
    Zeinalov, B. S.
    Kerimov, A. Kh.
    Guliev, F. A.
    Musaev, I. N.
    Alizade, A. M.
    Adzhalov, O. V.
    [J]. ONKOUROLOGIYA, 2011, 7 (01): : 62 - 65
  • [9] Osteonecrosis of the jaw in cancer patients with bone metastases treated with zoledronic acid: The focus is prevention
    Vormola, R.
    Ortega, C.
    Montemurro, F.
    Faggiuolo, R.
    Nanni, D.
    Goia, F.
    Aglietta, M.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI72 - XI72
  • [10] A COMPARISON OF DENOSUMAB VERSUS ZOLEDRONIC ACID FOR THE PREVENTION OF SKELETAL-RELATED EVENTS IN BREAST CANCER PATIENTS WITH BONE METASTASES
    Fujiwara, Yasuhiro
    Stopeck, Alison
    de Boer, Richard
    Lichinitser, Mikhail
    Tonkin, Katia
    Yardley, Denise
    Fan, Michelle
    Jiang, Qi
    Jun, Susie
    Dansey, Roger
    Braun, Ada
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 12 - 12
12345